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Abstract 
The low-density lipoprotein receptor gene (LDLR) in body is characterized by several single nucleotide 
polymorphisms (SNPs) that influence normal variations of plasma lipid profiles. The cynomolgus macaques 
(Macaca fascicularis) are widely used animals as models for investigating the response of plasma cholesterol to 
dietary cholesterol, but little is known about genetic variation in its LDLR gene. In this research, genetic 
diversity in the 3’UTR of LDLR gene was studied using isolated DNAs of 22 cynomolgus macaques which 
have differences in responsiveness to atherogenic diets.  
 
------------------------------------------------------------------------ 
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The results showed that the 3’UTR sequence of LDLR gene had lower genetic diversity (nucleotide 
composition, number of nucleotide difference, nucleotide diversity, genetic distance, substitution pattern) than 
human. There are 4 polymorphic sites distributed in 6 haplotypes. Four polymorphic sites were located on *42, 
*167, *210, and *290. Six identified haplotypes were haplotype I (GGAC), II (GGAT), III (GGGT), IV 
(AGGT), V (GGGC), and VI (GCGC) with haplotype diversity 0.745% ± 0.064%. Haplotype I – V are 
parsimony haplotypes, while haplotype VI is singleton haplotype. The obtained polymorphism will become 
basic information to improve understanding and interpretation of data from hypercholesterolemial studies 
conducted in this species. 
Keywords: 3’UTR; Genetic variations; LDLR gene; Macaca fascicularis. 
1. Introduction 
The low-density lipoprotein receptor (LDL-R) is a surface cell receptor that plays a crucial role in the receptor-
mediated pathway of lipoprotein metabolism [1]. Mutations that render the low-density lipoprotein receptor 
gene (LDLR) defective cause familial hypercholesterolemia (FH), an inherited autosomal dominant disease with 
hallmarks of elevated plasma LDL-cholesterol (LDL-C) levels and premature coronary heart disease (CHD). 
Although most individuals who suffer from CHD do not have FH and their plasma lipoprotein levels are within 
the reference range, there is an unequivocal evidence that lowering serum cholesterol reduces the risk of CHD 
events [2]. Thus, because of its pivotal role in lipid metabolisms, a quantitative change of LDLR gene 
expression is plausibly associated with risk for CHD, and warrants association studies of common genetic 
variations in non-coding regions of the LDLR gene that may influence its expression at transcriptional or post-
transcriptional mRNA levels [3,4]. Several studies have shown associations between genetic variations in the 
LDLR gene and plasma levels of LDL [5-8]. For example, an association between high plasma LDL-cholesterol 
levels and the absence of a Pvu II restriction site in intron 15 has been reported in normolipidemic Norwegian 
and German populations [9-10]. While cynomolgus macaques (Macaca fascicularis) are widely used as models 
to identify metabolic predictor for hyperresponsiveness to dietary cholesterol and etiology of atherosclerosis in 
human, it is presently unknown whether they exhibit polymorphisms of similar functional relevance at the 
LDLR gene. 
The human LDLR gene located on chromosome 19 p13.1-3, consist of 18 exons spanning 45 kb, and contains 
multiple Alu insertions which are involved in several large deletions causing FH [1]. A high Alu density occurs 
at the 3’ untranslated region (3’UTR) of this gene, whose 2.5 kb comprise almost half of the whole mRNA [11]. 
Several studies showed evidence that the 3’UTR of the LDLR gen can be important site of post-transcriptional 
regulation [12-13]. Therefore, this research was focused to characterize genetic diversity within the 3’UTR of 
the LDLR gene in twenty two of cynomolgus macaques which were differences responsiveness to atherogenic 
diet. The research purposed to identify single nucleotide polymorphism (SNP) within 3’UTR of LDLR gene and 
its association with  responsiveness  to atherogenic diet. The results showed that there are 4 polymorphic sites 
distributed in 6 haplotypes. Four polymorphic sites were located on *42, *167, *210, and *290 and Six 
identified haplotypes were haplotype I (GGAC), II (GGAT), III (GGGT), IV (AGGT), V (GGGC), and VI 
(GCGC) with haplotype diversity 0.745% ± 0.064%.  
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2. Materials and Methods 
2.1.  Animals 
Blood samples were obtained from 22 adult males of cynomolgus macaques (Macaca fascicularis) from 
captivity in Primate Research Center Bogor Agricultural University, Indonesia. The 22  cynomolgus macaques 
were grouped based on the responsiveness to atherogenic diet. Used animals and their responsiveness to 
atherogenic diet shown in Table 1. All treatment procedures applied on the animal had been approved by the 
Institutional Animal Care and Use Committee (IACUC) with protocol number 12-B009-IR. 
Table 1: Animals used in this study and their grouping based on responsiveness to atherogenic diet. 
No 
Animals  
(Tatto) 
Responsiveness  
No 
Animals  
(Tatto) 
Responsiveness  
1 T3707 Hypo- 12 FE7777 Hyper- 
2 K30 Hypo- 13 T3536 Hyper- 
3 FC8501 Hyper- 14 C2480 Hyper- 
4 T3049 Hyper- 15 T3303 Hyper- 
5 FG7998 Hyper- 16 FG7909 Hyper- 
6 T3307 Hyper- 17 T3300 Hyper- 
7 T3700 Hyper- 18 C0750 Hyper- 
8 T3278 Hyper- 19 FC9015 Hyper- 
9 FC9113 Hyper- 20 C4927 Hyper- 
10 9695 Hyper- 21 C0613 Exstreme  
11 C4939 Hyper- 22 T3535 Ekstreme 
 
2.2. Genomic DNA Extraction 
Genomic DNA was extracted from all whole-blood samples using the QIAamp™ DNA Mini Kit (QIAGEN, 
Hilden, Germany) in accordance with manufacturer’s instructions  
2.3. Primer Design, Amplification, and Sequencing 
The primer pairs used for amplification of 3’UTR was designed based on the sequences of the rhesus 
cynomolgus macaque LDLR gene (http://genome.ucsc.edu, GenBank accession number AY466854) using 
Primer3 program (http://primer3.wi.mit.edu/). The primers were F: 5’-GAGGGATCAGGATGTGGGAG-3’ and 
R: 5’-ACCACGGATTCAGCCAGATC-3’. Reactions were conducted in a 25 µL volume that containes  5 µL 
genomic DNA, 1 µL of each primer 10 pmol, 12.5 μL KAPA HotStart ready mix Kit (buffer solution, dNTP and 
Taq polymerase enzyme) and 5.5 μl nuclease free water. Amplification was performed using a GeneAmp® PCR 
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1000 pb 
  750 pb 
  500 pb 
  250 pb 
System 9700 thermal cycler (Applied Biosystems, Foster City, CA) and the cycling parameters were as follows: 
denaturation at 94oC for 5 min followed by 40 cycles. Each cycle consisted of denaturation at 94oC for 30 s, 
annealing  at 55 oC for 30 s, and extension at 72 oC for 7 min. The post extention at 25 oC for 4 min. Amplicons 
were visualized on a transilluminator following agarose gel electrophoresis to check band specificity and 
sufficiency for subsequent sequence analysis. DNA fragments were then purified using the MinElute Qiagen Kit 
(QIAGEN, Hilden, Germany) in accordance with manufacturer’s instructions, and sequencing was performed in 
the First BASE Laboratories Sdh Bhd (Malaysia). 
2.4. Sequences and Data Analysis 
Geneious 7.0.2 (http://geneious.en.softonic.com, the 30-day trial version) was used to edit and assess the quality 
of sequence data. Consensus sequences were obtained by combining forward and reverse strands for each 
amplicon and aligning them to the reference sequences of Macaca fascicularis (The Genbank accession number 
XM_005587996.2). Statistical summaries, including nucleotide composition, number of pairwise differences, 
nucleotide diversity (π), genetic distance, phylogenetic tree, and pattern heterogeneity were conducted in Mega-
6 [14]. Polymorphic sites, gene diversity, and haplotypes analysis were conducted in DnaSP [15]. In silico 
prediction of transcription factor binding sites at the polymorphic sites located in the 3’UTR was using 
TFSEARCH (http://www.cbrc.jp/research/db/ TFSEARCH.html).  
3. Results  
3.1. Amplification and Sequencing of 3’UTR 
3’UTR’s of the 22 DNA samples of cynomolgus macaques were successfully amplified using forward and 
reverse primers designed using Primer3 program. The PCR product was in accordance to the expected result, i.e. 
750 bp in size (Figure 1). The sequencing results shown that the amplification product consists of 114 bp as part 
of intron 17, 36 bp was exon 18 and 600 bp was part of 3’UTR located between *1 and *600 positions. The 
positioning ranges were divided in parallel to the reference in the GenBank (accession number 
XM_005587996.2), while the numbering was based on the nomenclature proposed by Dunnen dan Antonarakis 
[16].  
 
Figure 1: DNA band of 750 bp produced by PCR amplification 
750 bp 
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3.2. Nucleotide Variations among 3’UTR Sequences   
The nucleotide compositions parallelization of the 3’UTR sequences of the 22 blood samples are shown in 
Table 2. As shown in Table 2, the nucleotide compositions of the 3’UTR sequences were almost equals. The 
ranges of composition difference in individual nucleotide of each sequence just 0 – 0.2 %.         
Table 2: Nucleotide compositions of 3’UTR sequences 
Animals 
(Tattoo) 
No. of 
nucleotides 
(bp) 
 
Nucleotide compositions (%) 
T C A G 
T4927 600 24,0 27,2 23,8 25,0 
FC8501 600 24,2 27,0 23,8 25,0 
K30 600 24,2 27,0 23,7 25,2 
T3707 600 24,2 27,0 23,8 25,0 
T3535 600 24,0 27,2 23,7 25,2 
9695 600 24,0 27,2 23,7 25,2 
C0613 600 24,0 27,3 23,7 25,0 
T3049 600 24,2 27,0 23,7 25,2 
T3536 600 24,2 27,0 23,8 25,0 
T3700 600 24,2 27,0 23,7 25,2 
C4939 600 24,2 27,0 23,8 25,0 
T3278 600 24,2 27,0 23,7 25,2 
T3303 600 24,2 27,0 23,7 25,2 
FC9015 600 24,0 27,2 23,7 25,2 
FE7777 600 24,2 27,0 23,7 25,2 
T3307 600 24,2 27,0 23,7 25,2 
T3300 600 24,0 27,2 23,7 25,2 
FG7909 600 24,2 27,0 23,7 25,2 
C750 600 24,0 27,2 23,7 25,2 
FG7998 600 24,0 27,2 23,7 25,2 
C2480 600 24,2 27,0 23,7 25,2 
FC9113 600 24,0 27,2 23,7 25,2 
Average   24,1 27,1 23,7 25,1 
 
Distance pairwise analysis using number of differences option showed that the the nucleotide differences among 
the 3’UTR paired sequences ranged from 0 to 3 (Table 3) with an average of 1.017 and a diversity (π) of 
0.001696. Sequences having highly nucleotide differences listed in order from the highest: C0613, T3707, 
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C4939 and T4927, and FC8501 and T3536. The C0613 sequence had 3 nucleotide differences to each of the 
FC8501, T3707 and T3536 sequences. The T3707 sequence had also 3 nucleotide differences to each of C0613 
and T4927 sequences. It was also found that the C4939 sequence had 3 nucleotide differences to each of the 
C0613 and T4927 sequences. Furthermore, the T4927 had 3 nucleotides lower than that of each of the T3707 
and C4939 sequences, and both the FC8501 and T3536 sequences had also 3 nucleotides lower than that 
belongs to the C0613 one.                                        
Table 3: Matrix of nucleotide differences among 3’UTR paired sequences. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
T4927 
                     
 
FC8501 1 
                    
 
K30 2 1 
                   
 
T3707 3 2 1 
                  
 
T3535 1 2 1 2 
                 
 
9695 1 2 1 2 0 
                
 
C0613 2 3 2 3 1 1 
               
 
T3049 2 1 0 1 1 1 2 
              
 
T3536 1 0 1 2 2 2 3 1 
             
 
T3700 2 1 0 1 1 1 2 0 1 
            
 
C4939 3 2 1 0 2 2 3 1 2 1 
           
 
T3278 2 1 0 1 1 1 2 0 1 0 1 
          
 
T3303 2 1 0 1 1 1 2 0 1 0 1 0 
         
 
FC9015 1 2 1 2 0 0 1 1 2 1 2 1 1 
        
 
FE7777 2 1 0 1 1 1 2 0 1 0 1 0 0 1 
       
 
T3307 2 1 0 1 1 1 2 0 1 0 1 0 0 1 0 
      
 
T3300 1 2 1 2 0 0 1 1 2 1 2 1 1 0 1 1 
     
 
FG7909 2 1 0 1 1 1 2 0 1 0 1 0 0 1 0 0 1 
    
 
C0750 1 2 1 2 0 0 1 1 2 1 2 1 1 0 1 1 0 1 
   
 
FG7998 1 2 1 2 0 0 1 1 2 1 2 1 1 0 1 1 0 1 0 
  
 
C2480 2 1 0 1 1 1 2 0 1 0 1 0 0 1 0 0 1 0 1 1 
 
 
FC9113 1 2 1 2 0 0 1 1 2 1 2 1 1 0 1 1 0 1 0 0 1  
 
Genetic distances obtained based on pairwise distance analysis using 2-parameter Kimura model ranged from 
0.000 (0%) to 0.005 (0.5%). Identical paired sequences had 0.0% genetic distance, while paired sequence with 3 
nucleotide differences had 0.5% genetic distance. The low genetic distance was shown by phylogenetic tree that 
formed all nodus with bootstrap values less than 75% (Figure 2). 
The substitution patterns test observed for the paired sequences using disparity index resulted ini P values that 
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higher than 0.05 (Table 4). The P values that higher than 0.05 indicated that there no differences in substitution 
patterns observed for the paired sequences (homogeneity in substitution patterns). This meant that nucleotide 
differences occurred among the paired sequences were insignificant.       
Table 4: Homogeneity test of substitution patterns among 3’UTR paired sequences. 
 
 
Figure 2: Phylogenetic tree of 3’UTR sequences using Neighbor Joining with 1000 times bootstrap. Values on 
each branch of the tree indicate the bootstrap values. 
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3.3. Single Nucleotide Polimorphism and Haplotype 
3’UTR sequences analysis of the 22 cynomolgus macaques identified 6 haplotypes from 4 single nucleotide 
polymorphisms (SNPs) at *42, *167, *210, and *290 positions (Table 5). Polymorphic sites consisted of tree 
parsimony variable sites (*42, *210, and *290) and one singleton variable (*167). Results of TFSEARCH 
program revealed no binding site of transcription factors within or in the vicinity of the polymorphic sites 
indicating that the identified polymorphisms were nonfunctional. A Functional polymorphism is defined as a 
site that causes binding site appearance or disappearance of new transcription factors. Likewise, the haplotype 
products are non-functional [17]. 
The six identified haplotypes consisted of 5 common haplotypes, i.e. haplotypes I (GGAC), II (GGAT), III 
(GGGT), IV (AGGT), and V (GGGC), and 1 singleton haplotype (specific), i.e. haplotype VI (GCGC) with 
diversity of 0.745 ± 0.064. The haplotype V was similar to the reference haplotype of cynomolgus macaques in 
the GenBank. The Haplotype III contained the highest number of individuals, i.e. nine individuals, whilst the 
haplotypes I and V had the least, i.e. one individual each (Table 5). The common haplotypes performed 
responsiveness variations as hypo-responsiveness, hyper-responsiveness, and extreme, whilst the specific 
haplotype VI (GCGC) that belonged only to C0613 individual showed extreme responsiveness to atherogenic 
diet (Table 1).                      
Table 5: Identified SNP in 3’UTR of LDLR gene that in parallel to the GenBank reference (accession number 
XM_005587996.2) 
Haplotypes Position whitin the 3’UTR No. of 
individuals 
No. of  tattoo 
 
*42 *167 *210 *290 
Ref G G G C - - 
I G G A C 1 T4927 
II G G A T 2 FC8501, T3536 
III G G G T 9 K30, T3049, T3700, T3278, T3303, 
FE7777, T3307, FG7909, C2480 
IV A G G T 2 T3707, C4939 
V G G G C 7 T3535, 9695, FC9015, T3300, C0750, 
FG7998, FC9113 
VI G C G C 1 C0613 
 
4. Discussion 
The 3’UTR sequences have long been recognized as a regulatory region that is important for the appropriate 
expression of many genes [18-19]. It contains cis-elements that affect the stability of transcripts, and/or 
influence the translation by interacting with the 5’ sequence of the transcripts. For example, a stretch of AU-rich 
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element (ARE) containing an AUUUA penta-nucleotide motif serves as a recognition site for specific proteins 
that increase the rate of poly A tail shortening and mRNA degradation. The 3’UTR of the human LDLR genes 
includes three regions each containing an ARE, and Wilson et al. [20] demonstrated that each element shortened 
the half-life of the reporter gene transcript by approximately 30% when introduced into the 3’UTR of the β 
globin gene in a tissue culture based system. Furthermore, previously study shown that the removal of two of 
the three AREs in the 3’UTR of the LDLR gene leads to more stable transcripts and increased steady state levels 
of LDLR mRNA in mice [21]. Therefore, common SNPs within or near these cis-elements may affect the 
binding of proteins to ARE or other control elements and hence alter gene expression in general human 
populations. 
Overall, the 3’UTR sequences of LDLR gene of the cynomolgus macaques indicated the low genetic diversities 
(average of nucleotide differences, nucleotide diversity, genetic distances, and substitution patterns). The 
nucleotide diversity (π) is an accurate parameter in order to describe the genetic diversities. Positive elements 
using nucleotide diversity (π) are independent on the sample sizes as well as on the DNA’s lengths [22-23]. This 
means that the probability that small sample sizes may extensively depict the actual conditions of population. 
The nucleotide diversity (π) obtained in this research (0.001696) is far less than the nucleotide diversity (π) of 4 
country populations, Africa, Asia, Caucasus, and America, each has π of 0.422 ± 0.046, 0.545 ± 0.029, 0.503 ± 
0.027 and 0.492 ± 0.011 respectively [24]. 
The number of SNPs and haplotypes founded in this research were smaller than that of reported in human body. 
As reported by Fagundes et al. [24] that there were 21 polymorphic sites distributed within 15 haplotype 
observed in 111 3’UTR sequences of LDLR gene (with 784 nucleotide numbers) of 4 country’s populations. 
Meanwhile, the haplotype diversities were still in the range of haplotype diversities of the 4 country’s 
populations i.e. 0.751 – 0.860. The SNPs and haplotypes are common genetic variations used as genetic markers 
for normal profile variations of lipid plasma. In human, 2 SNPs within 3’UTR have been reported to be potential 
as the lipid response markers for certain populations; the Caucasus population [25]. Also, the presence of 1 
haplotype out of 6 haplotypes produced by 5 polymorphic sites which related to lowering lipid response caused 
by introduction of simvastatin [26]. 
The presence of haplotype VI (GCGC) associated with extreme responsiveness to the atherogenetic diet 
indicates that the 3’UTRs in cynomolgus macaques have also common genetic associated with response 
variations to the atherogenic diet that has not been published previously. Although these results are potentially 
important, they must be interpreted with caution until confirmed. The association of GCGC specific haplotype 
within 3’UTR with extreme responsiveness of cynomolgus macaques to the atherogenetic diets has promoted 
the SNP g.*167G>C as being potentially used as genetic markers. The presence of the non functional SNP 
g.*167G>C indicates the possibility of the SNP located in disequilibrium linkage with other SNPs in the same 
gene or in different gene that are functional to extremely increase the cholesterol plasma when atherogenetic 
diets are given. 
Generally, SNPs or haplotypes identifications in cynomolgus macaques are mainly related to the origin or 
geographical distributions [27-29]. Investigations on individual variations that affect susceptibilities or other 
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defects are very view compared to biomedical researches on cynomolgus macaques. Some of them are genetic 
variations against malaria susceptibility [17], drug safety [30] and neurobiology reactivity due to stress [31]. 
Identification of SNPs within the 3’UTR of LDLR gene as genetic markers of responsiveness is an important 
advancement in the investigations using cynomolgus macaques as models in order to understand the 
atherosclerosis. These are due to most of researches conducted using animals to investigate the responsiveness 
to the atherogenetic diets is not yet based on the appropriate genetic variability. 
Differences in the results of toxicology and pharmacokinetic investigations on cynomolgus macaques [32-34] 
might be related to the genetic diversity. Therefore, researches conducted to know the individual genetic 
diversity is expected being able to explain the variability phenomena. This research is an initial stage as to 
understand the genetic diversity of the cynomolgus macaque LDLR gene. Researches on genetic diversity of the 
LDLR gene is still needed to be conducted in other regions in order to know other genetic variations and their 
associations with the responsiveness to atherogenic diets.  
5. Conclusion  
The research revealed that the 3’UTR of LDLR gene of cynomolgus macaques had genetic diversity levels that 
were lower than the ones belong to human being. Four identified polymorphic sites distributed in six haplotypes 
indicated the presence of genetic variation that potentially be used as genetic markers for responsiveness of 
cynomolgus macaques to the atherogenic diets.         
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